| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 07/02/2009 | US20090170857 Method for healing a wound using a direct vasodilator |
| 07/02/2009 | US20090170853 4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-ol; inhibit the tyrosine kinase activity of endothelial and fibroblast growth factors receptors; angiogenesis inhibitor; anticarcinogenic agent (hepatocellular cancer, colorectal cancer or non-small cell lung cancer) |
| 07/02/2009 | US20090170836 New inhibitors of histone deacetylase |
| 07/02/2009 | US20090170822 2-Methylene-20-Methyl-19,24,25,26,27-Pentanor-Vitamin D Analogs |
| 07/02/2009 | US20090170821 2-Methylene-(20S,25S)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170820 2-Methylene-(20S,25R)-19,26-Dinor-Vitamin D Analogs |
| 07/02/2009 | US20090170819 (20R)-23,23-Difluoro-2-Methylene-19-Nor-Bishomopregnacalciferol-Vitamin D Analogs |
| 07/02/2009 | US20090170818 Arresting the proliferation of undifferentiated cells and inducing their differentiation; anticancer agents; treating psoriasis, wrinkles, slack skin, dry skin, insufficient sebum secretion, autoimmune disorders, inflammatory diseases, renal osteodystrophy. and obesity; little, if any, calcemic activity |
| 07/02/2009 | US20090170809 Pectic Polysaccharides Isolated from Fruit Pods of Okra |
| 07/02/2009 | US20090170788 Novel use of 1, 2, 3, 4, 6-penta-o-galloyl-beta-d-glucose |
| 07/02/2009 | US20090170201 Compositions and methods of making embryonic stem cells |
| 07/02/2009 | US20090170197 Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R) |
| 07/02/2009 | US20090169652 Personal Care Compositions |
| 07/02/2009 | US20090169651 Anti-skin damage compositions with complimentary dual mode of action |
| 07/02/2009 | US20090169543 Method for regulating immune function in primates using the Foxp3 protein |
| 07/02/2009 | US20090169539 Pdgf fusion proteins incorporated into fibrin foams |
| 07/02/2009 | US20090169528 Keratinocytes expressing exogenous angiogenic growth factors |
| 07/02/2009 | US20090169491 Peptides Having Activities of Insulin Like Growth Factor-1 and their Uses |
| 07/02/2009 | US20090169486 Biomedical foam articles |
| 07/02/2009 | DE102005053384B4 Mittel zur Behandlung von Verätzungen mit Fluorwasserstoffsäure Agents for the treatment of burns with hydrofluoric acid |
| 07/02/2009 | CA2747569A1 Use larch wood material for treating inflammation |
| 07/02/2009 | CA2710130A1 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 07/02/2009 | CA2710067A1 Oxadiazole derivatives active on sphingosine-1-phosphate (s1p) |
| 07/02/2009 | CA2709937A1 Halogenated analogues of anti-fibrotic agents |
| 07/02/2009 | CA2708449A1 Method for improving the therapeutic efficacy of the curcuminoids and their analogues |
| 07/02/2009 | CA2707447A1 Sulfonyl-substituted 6-membered ring derivative |
| 07/01/2009 | EP2075330A1 A method of producing a cultured skin device |
| 07/01/2009 | EP2075255A1 Human FGF-23 gene and gene expression products |
| 07/01/2009 | EP2074995A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: methods of using and compositions thereof |
| 07/01/2009 | EP2074128A1 Therapeutic pyrazolyl thienopyridines |
| 07/01/2009 | EP2073806A2 Use of spiro-oxindole compounds as therapeutic agents |
| 07/01/2009 | EP2073787A2 Use of an active ingredient derived from flax that acts on the papillary dermis, for its anti-ageing action |
| 07/01/2009 | EP1569668A4 An organic extract of geum japonicum thumb variant and use thereof |
| 07/01/2009 | EP1537075B1 Diarylurea derivatives and their use as chloride channel blockers |
| 07/01/2009 | EP1471054B1 Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these |
| 07/01/2009 | EP1414428B1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 07/01/2009 | EP1406858B1 Substituted 4-aminocyclohexanols |
| 07/01/2009 | EP1352637B1 Hair growth inhibitors and compositions containing the same |
| 07/01/2009 | EP1312675B1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 07/01/2009 | EP1203025B1 Novel method and composition for inhibition of angiogenesis using antagonists based on mmp-9 and beta1 integrins |
| 07/01/2009 | CN100506846C Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |
| 07/01/2009 | CN100506845C IFNAR2 mutants, their production and use |
| 07/01/2009 | CN100506831C Phosphonic acid compounds as inhibitors of serine proteases |
| 07/01/2009 | CN100506815C Piperidinyl targeting compounds that selectively bind integrins |
| 07/01/2009 | CN100506277C Combinations of antibodies selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and other therapeutic agents |
| 06/30/2009 | US7553966 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 06/30/2009 | US7553939 Genes that encode cell surface molecules with conserved IgV and mucin domains; diagnosis or staging of cancer; treatment of an immunological disorder; detecting a predisposition to asthma |
| 06/30/2009 | US7553918 pH-sensitive polymer |
| 06/30/2009 | US7553877 Use of 2-hydroxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrene compounds glucocorticoid receptor agonists to treat certain inflammatory conditions such as arthritis, asthma |
| 06/30/2009 | US7553867 Furan or thiophene derivative and medicinal use thereof |
| 06/30/2009 | US7553852 Caspase inhibitors and uses thereof |
| 06/30/2009 | US7553663 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553660 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 06/30/2009 | US7553492 Gene overexpression/underexpression; antibodies; drug screening; kits |
| 06/30/2009 | US7553488 Chemokine inhibitors; for treatment of gout; for inhibiting migration of neutrophils involved in pathogenesis |
| 06/30/2009 | CA2554696C Androgen receptor modulators |
| 06/25/2009 | WO2009078798A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 06/25/2009 | WO2009078366A1 α-LIPOIC ACID NANOPARTICLE AND METHOD FOR PRODUCING THE SAME |
| 06/25/2009 | WO2009077995A1 Cosmetic use of acid ceramidase type proteins |
| 06/25/2009 | WO2009077693A2 Compositions containing at least one naphthoic acid derivative, benzoyl peroxide and at least one film-forming agent |
| 06/25/2009 | WO2009077671A1 Solid inorganic/organic hybrid with modified surface |
| 06/25/2009 | WO2009077670A1 Organic/inorganic hybrid nanoparticulates made from iron carboxylates |
| 06/25/2009 | WO2009077635A2 Anti-inflammatory, anti-edematous and anti-erythematous composition, method for obtaining same and use thereof |
| 06/25/2009 | WO2009056754A9 Use of econazole or salts thereof for treating acne |
| 06/25/2009 | WO2009040420A3 Use of a monoterpene to increase tissue repair |
| 06/25/2009 | WO2008113450A3 Use of chroman-4-on-derivatives |
| 06/25/2009 | WO2008076709A3 Compositions and methods of inducing hair growth utilizing continus coggygria |
| 06/25/2009 | WO2008046084A3 Spiroheterocyclic compounds and their uses as therapeutic agents |
| 06/25/2009 | US20090163600 Anti-Inflammatory Agent and Cancer-Preventive Agent Comprising Canolol or Prodrug Thereof and Pharmaceutical, Cosmetic and Food Comprising the Same |
| 06/25/2009 | US20090163556 Glycinamide derivatives as raf-kinase inhbitors |
| 06/25/2009 | US20090163509 Method for healing a wound using an alpha-adrenergic antagonist |
| 06/25/2009 | US20090163497 Compounds Useful as Antagonists of CCR2 |
| 06/25/2009 | US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 06/25/2009 | US20090163481 Ppar-delta ligands and methods of their use |
| 06/25/2009 | US20090163480 Modified amino acids, pharmaceuticals containing these compounds and method for their production |
| 06/25/2009 | US20090163473 (PYRIDO/THIENO)-[f]-OXAZEPINE-5-ONE DERIVATIVES |
| 06/25/2009 | US20090163469 Organic Compounds |
| 06/25/2009 | US20090163460 Diagnostics and therapeutics for early-onset menopause |
| 06/25/2009 | US20090162452 EB Matrix Production From Animal Tissue And Its Use For Tissue Repair |
| 06/25/2009 | US20090162423 Formulations for cosmetic and wound care treatments with photosensitizes as fluorescent markers |
| 06/25/2009 | US20090162406 Wound healing with zeolite-based hemostatic devices |
| 06/25/2009 | US20090162348 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 06/25/2009 | US20090162304 Compositions and methods for treating skin conditions in mammals |
| 06/25/2009 | US20090162299 Caffeine salt complexes and methods for using the same in the prevention or treatment of cancer |
| 06/25/2009 | DE3943838B4 Kompositionen zur topischen Anwendung enthaltend Cyclosporine Compositions for topical application containing Cyclosporine |
| 06/25/2009 | DE102007062691A1 Wirkstoffkombinationen aus Anisfruchtextrakt und einem oder mehreren 2,3-Dibenzylbutyrolactonen Active compound combinations of anise fruit and one or more 2,3-Dibenzylbutyrolactonen |
| 06/25/2009 | CA2709126A1 Pharmaceutically acceptable salts of methyl (3-{ [[3-(6- amino- 2-butoxy-8-oxo-7, 8-dihydro-9h-purin-9-yl) propyl] (3- morpholin-4-ylpropyl) amino] methyl }phenyl) acetate and their use in therapy |
| 06/25/2009 | CA2707010A1 .alpha.-lipoic acid nanoparticles and methods for preparing thereof |
| 06/25/2009 | CA2706655A1 Compositions comprising at least one naphthoic acid derivative and benzoyl peroxide, and at least one film-forming agent methods for preparing same, and uses thereof |
| 06/25/2009 | CA2699496A1 Solid inorganic/organic hybrid with modified surface |
| 06/25/2009 | CA2699480A1 Organic/inorganic hybrid nanoparticulates made from iron carboxylates |
| 06/24/2009 | EP2072519A1 Diaryl ketimine derivative |
| 06/24/2009 | EP2072494A1 Cosmetic and pharmaceutical compositions |
| 06/24/2009 | EP1951261A4 Compositions and methods for treating inflammatory disorders |
| 06/24/2009 | EP1499746A4 Method to inhibit cell growth using oligonucleotides |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | EP1284977B1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 06/24/2009 | EP1152761B1 Use of 5-ht3 receptor antagonists for treating musculoeskeletal diseases |
| 06/24/2009 | CN101466357A Direct cellular energy delivery system |
| 06/24/2009 | CN100503611C New use of specific cyclolignans |